Sight Sciences, Inc. FDA Approvals

0 new drug approvals and 8 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
TearCare System510(k)Aug 18, 2026Ophthalmic	Ophthalmic	510(k)Substantially Equivalent (Special)	Aug 18, 2026
OMNI Ultra Surgical System (1-110)510(k)Aug 4, 2026General Hospital	General Hospital	510(k)Substantially Equivalent (Traditional)	Aug 4, 2026
TearCare MGX System510(k)Apr 27, 2026Ophthalmic	Ophthalmic	510(k)Substantially Equivalent (Traditional)	Apr 27, 2026
TearCare MGX System510(k)Apr 15, 2025Ophthalmic	Ophthalmic	510(k)Substantially Equivalent (Traditional)	Apr 15, 2025
TearCare MGX System510(k)Dec 27, 2023Ophthalmic	Ophthalmic	510(k)Substantially Equivalent (Traditional)	Dec 27, 2023
OMNI Surgical System510(k)Aug 25, 2023General Hospital	General Hospital	510(k)Substantially Equivalent (Special)	Aug 25, 2023
TearCare System510(k)Dec 21, 2021Ophthalmic	Ophthalmic	510(k)Substantially Equivalent (Traditional)	Dec 21, 2021
OMNI Surgical System510(k)Mar 1, 2021General Hospital	General Hospital	510(k)Substantially Equivalent (Traditional)	Mar 1, 2021